ALIGNMENT HEALTHCARE INC (ALHC) Fundamental Analysis & Valuation

NASDAQ:ALHC • US01625V1044

Current stock price

21.9 USD
+0.95 (+4.53%)
At close:
22.07 USD
+0.17 (+0.78%)
After Hours:

This ALHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALHC Profitability Analysis

1.1 Basic Checks

  • ALHC had negative earnings in the past year.
  • In the past year ALHC had a positive cash flow from operations.
  • ALHC had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ALHC reported negative operating cash flow in multiple years.
ALHC Yearly Net Income VS EBIT VS OCF VS FCFALHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • ALHC's Return On Assets of -0.07% is in line compared to the rest of the industry. ALHC outperforms 47.00% of its industry peers.
  • ALHC's Return On Equity of -0.40% is in line compared to the rest of the industry. ALHC outperforms 52.00% of its industry peers.
  • ALHC has a Return On Invested Capital (2.29%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.07%
ROE -0.4%
ROIC 2.29%
ROA(3y)-13.82%
ROA(5y)-19.2%
ROE(3y)-74.31%
ROE(5y)-69.91%
ROIC(3y)N/A
ROIC(5y)N/A
ALHC Yearly ROA, ROE, ROICALHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

1.3 Margins

  • ALHC has a Operating Margin of 0.37%. This is in the lower half of the industry: ALHC underperforms 62.00% of its industry peers.
  • Looking at the Gross Margin, with a value of 12.37%, ALHC is doing worse than 68.00% of the companies in the same industry.
  • ALHC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.37%
PM (TTM) N/A
GM 12.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-6.51%
ALHC Yearly Profit, Operating, Gross MarginsALHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 -10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ALHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALHC is destroying value.
  • Compared to 1 year ago, ALHC has more shares outstanding
  • Compared to 5 years ago, ALHC has more shares outstanding
  • Compared to 1 year ago, ALHC has an improved debt to assets ratio.
ALHC Yearly Shares OutstandingALHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALHC Yearly Total Debt VS Total AssetsALHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 5.77 indicates that ALHC is not in any danger for bankruptcy at the moment.
  • ALHC has a Altman-Z score of 5.77. This is amongst the best in the industry. ALHC outperforms 88.00% of its industry peers.
  • ALHC has a debt to FCF ratio of 2.86. This is a good value and a sign of high solvency as ALHC would need 2.86 years to pay back of all of its debts.
  • ALHC has a better Debt to FCF ratio (2.86) than 71.00% of its industry peers.
  • ALHC has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.80, ALHC is not doing good in the industry: 72.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 2.86
Altman-Z 5.77
ROIC/WACC0.26
WACC8.75%
ALHC Yearly LT Debt VS Equity VS FCFALHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.71 indicates that ALHC should not have too much problems paying its short term obligations.
  • ALHC's Current ratio of 1.71 is fine compared to the rest of the industry. ALHC outperforms 70.00% of its industry peers.
  • A Quick Ratio of 1.71 indicates that ALHC should not have too much problems paying its short term obligations.
  • The Quick ratio of ALHC (1.71) is better than 73.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.71
ALHC Yearly Current Assets VS Current LiabilitesALHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ALHC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 98.51% over the past year.
  • The Revenue has grown by 46.06% in the past year. This is a very strong growth!
  • The Revenue has been growing by 32.71% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)46.06%
Revenue growth 3Y40.16%
Revenue growth 5Y32.71%
Sales Q2Q%44.43%

3.2 Future

  • ALHC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 248.11% yearly.
  • Based on estimates for the next years, ALHC will show a very strong growth in Revenue. The Revenue will grow by 27.23% on average per year.
EPS Next Y4766.5%
EPS Next 2Y530.4%
EPS Next 3Y322.54%
EPS Next 5Y248.11%
Revenue Next Year31.33%
Revenue Next 2Y28.14%
Revenue Next 3Y26.71%
Revenue Next 5Y27.23%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALHC Yearly Revenue VS EstimatesALHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
ALHC Yearly EPS VS EstimatesALHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

3

4. ALHC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALHC. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 46.93, which means the current valuation is very expensive for ALHC.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ALHC.
  • The average S&P500 Price/Forward Earnings ratio is at 21.99. ALHC is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 46.93
ALHC Price Earnings VS Forward Price EarningsALHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K -1.5K -2K

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALHC indicates a slightly more expensive valuation: ALHC is more expensive than 65.00% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALHC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 39.54
EV/EBITDA 87.78
ALHC Per share dataALHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • ALHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALHC's earnings are expected to grow with 322.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y530.4%
EPS Next 3Y322.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALHC Dividend Analysis

5.1 Amount

  • No dividends for ALHC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALHC Fundamentals: All Metrics, Ratios and Statistics

ALIGNMENT HEALTHCARE INC

NASDAQ:ALHC (4/28/2026, 8:12:43 PM)

After market: 22.07 +0.17 (+0.78%)

21.9

+0.95 (+4.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners95.4%
Inst Owner Change-0.89%
Ins Owners3.73%
Ins Owner Change-7.64%
Market Cap4.47B
Revenue(TTM)3.95B
Net Income(TTM)-724.00K
Analysts85.26
Price Target25.96 (18.54%)
Short Float %9.24%
Short Ratio5.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)96.03%
Min EPS beat(2)67.92%
Max EPS beat(2)124.15%
EPS beat(4)4
Avg EPS beat(4)112.14%
Min EPS beat(4)61.17%
Max EPS beat(4)195.32%
EPS beat(8)7
Avg EPS beat(8)58.98%
EPS beat(12)10
Avg EPS beat(12)43.37%
EPS beat(16)13
Avg EPS beat(16)38.5%
Revenue beat(2)0
Avg Revenue beat(2)-0.86%
Min Revenue beat(2)-1%
Max Revenue beat(2)-0.73%
Revenue beat(4)2
Avg Revenue beat(4)1.06%
Min Revenue beat(4)-1%
Max Revenue beat(4)3.66%
Revenue beat(8)6
Avg Revenue beat(8)2.08%
Revenue beat(12)9
Avg Revenue beat(12)1.93%
Revenue beat(16)13
Avg Revenue beat(16)2.58%
PT rev (1m)1.45%
PT rev (3m)14.19%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.99%
EPS NY rev (1m)4.57%
EPS NY rev (3m)381.58%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)-0.88%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 46.93
P/S 1.13
P/FCF 39.54
P/OCF 31.98
P/B 24.96
P/tB 31.36
EV/EBITDA 87.78
EPS(TTM)-0.01
EYN/A
EPS(NY)0.47
Fwd EY2.13%
FCF(TTM)0.55
FCFY2.53%
OCF(TTM)0.68
OCFY3.13%
SpS19.33
BVpS0.88
TBVpS0.7
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.4%
ROCE 2.9%
ROIC 2.29%
ROICexc N/A
ROICexgc N/A
OM 0.37%
PM (TTM) N/A
GM 12.37%
FCFM 2.87%
ROA(3y)-13.82%
ROA(5y)-19.2%
ROE(3y)-74.31%
ROE(5y)-69.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-6.51%
F-Score6
Asset Turnover3.7
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 2.86
Debt/EBITDA 7.14
Cap/Depr 87.86%
Cap/Sales 0.68%
Interest Coverage 1.07
Cash Conversion 309.34%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.71
Altman-Z 5.77
F-Score6
WACC8.75%
ROIC/WACC0.26
Cap/Depr(3y)135.68%
Cap/Depr(5y)133.25%
Cap/Sales(3y)1.39%
Cap/Sales(5y)1.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y4766.5%
EPS Next 2Y530.4%
EPS Next 3Y322.54%
EPS Next 5Y248.11%
Revenue 1Y (TTM)46.06%
Revenue growth 3Y40.16%
Revenue growth 5Y32.71%
Sales Q2Q%44.43%
Revenue Next Year31.33%
Revenue Next 2Y28.14%
Revenue Next 3Y26.71%
Revenue Next 5Y27.23%
EBIT growth 1Y114.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year753.4%
EBIT Next 3Y157.48%
EBIT Next 5Y101.71%
FCF growth 1Y1801.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y302.44%
OCF growth 3YN/A
OCF growth 5Y79.26%

ALIGNMENT HEALTHCARE INC / ALHC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ALIGNMENT HEALTHCARE INC?

ChartMill assigns a fundamental rating of 4 / 10 to ALHC.


Can you provide the valuation status for ALIGNMENT HEALTHCARE INC?

ChartMill assigns a valuation rating of 3 / 10 to ALIGNMENT HEALTHCARE INC (ALHC). This can be considered as Overvalued.


Can you provide the profitability details for ALIGNMENT HEALTHCARE INC?

ALIGNMENT HEALTHCARE INC (ALHC) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ALHC stock?

The Earnings per Share (EPS) of ALIGNMENT HEALTHCARE INC (ALHC) is expected to grow by 4766.5% in the next year.